Natural Product: NPC165106

Natural Product IDNPC165106
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Terameprocol
IUPAC Name 4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene
Synonyms EM-1421; Terameprocol
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL90983
PubChem CID 476861
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001969] Dibenzylbutane lignans

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey ORQFDHFZSMXRLM-IYBDPMFKSA-N
Standard InCHI InChI=1S/C22H30O4/c1-15(11-17-7-9-19(23-3)21(13-17)25-5)16(2)12-18-8-10-20(24-4)22(14-18)26-6/h7-10,13-16H,11-12H2,1-6H3/t15-,16+
SMILES COc1cc(ccc1OC)C[C@H]([C@H](Cc1ccc(c(c1)OC)OC)C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   358.21 Volume:   391.297
?
Van der Waals volume.
Dense:   0.915 LogP:   3.059
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.046
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.95
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   12.0
TPSA:   36.92
?
Topological Polar Surface Area.
H-Bond Acceptor:   4.0
H-Bond Donor:   0.0 Rings:   2.0
Heavy Atoms:   4.0

MedChem Properties

QED Drug-Likeness Score:   0.646 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.626 Fsp3:   0.455
MCE-18:   28.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.324 Fluc inhibitor:   0.31
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.017
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.084
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.658 Promiscuous compounds:   0.114

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.556 MDCK Permeability:   -4.572
Pgp-inhibitor:   0.729 Pgp-substrate:   0.148
PAMPA:   0.007
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.187 30% Bioavailability (F30%):   0.84
50% Bioavailability (F50%):   0.983

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.432
Plasma Protein Binding (PPB):   89.628% Volume Distribution (VD):   0.143
Fu: 8.936%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.66
OATP1B3 inhibitor:   0.874 BCRP inhibitor:   0.836
BSEP inhibitor:   0.999

ADMET: Metabolism

CYP1A2-inhibitor:   0.987 CYP1A2-substrate:   0.785
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   1.0
CYP2C9-inhibitor:   0.5 CYP2C9-substrate:   0.998
CYP2D6-inhibitor:   0.323 CYP2D6-substrate:   0.999
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.959 CYP2C8-inhibitor:   1.0
HLM stability:   1.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.385 Half-life (T1/2):  1.311

ADMET: Toxicity

hERG Blockers:  0.46 hERG Blockers (10um):  0.831
Human Hepatotoxicity (H-HT):  0.596 Drug-induced Liver Injury (DILI):  0.438
AMES Toxicity:  0.258 Rat Oral Acute Toxicity:  0.12
Maximum Recommended Daily Dose:  0.051 Skin Sensitization:  0.813
Carcinogencity:  0.305 Eye Corrosion:  0.966
Eye Irritation:  0.997 Respiratory Toxicity:  0.08
Drug-induced Neurotoxicity:  0.452 Ototoxicity:  0.578
Hematotoxicity:  0.538 Drug-induced Nephrotoxicity:  0.647
Genotoxicity:  0.003 RPMI-8226 Immunitoxicity:  0.17
A549 Cytotoxicity:  0.197 Hek293 Cytotoxicity:  0.254
BCF:   2.751
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.483
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.329
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.143
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. stem n.a. DOI[10.1002/cjoc.20010190319]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. stem n.a. DOI[10.1016/j.tet.2008.10.079]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. stem n.a. PMID[11395273]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. stem n.a. PMID[18536373]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota aerial parts Erlang Mountain area of Sichuan Province, China 2007-SEP PMID[19413342]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. n.a. n.a. PMID[20681569]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO7374 Seseli montanum Species Apiaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7374 Seseli montanum Species Apiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7850 Schisandra propinqua Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11167 Prunus ssiori Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO9834 Veronica austriaca Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO6903 Lecanora straminea Species Lecanoraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO7128 Cynthia savignyi n.a. n.a. n.a. n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.57 % DOI[10.6019/CHEMBL4495564]
NPT20556 Single protein Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 14.64 % DOI[10.6019/CHEMBL4495564]
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = -2.57 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators
NPT692 Individual protein Histone deacetylase 6 Homo sapiens Inhibition = -12.68 % HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 11700.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 4400.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 8240.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 5970.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 6480.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 6980.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 9910.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 8820.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 4470.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 4180.0 nM PMID[9685239]
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 11080.0 nM PMID[9685239]
NPT3886 Cell line COS-1 Chlorocebus aethiops Inhibition = 18.5 % PMID[9685238]
NPT3886 Cell line COS-1 Chlorocebus aethiops Inhibition = 25.3 % PMID[9685238]
NPT3886 Cell line COS-1 Chlorocebus aethiops Inhibition = 45.0 % PMID[9685238]
NPT3886 Cell line COS-1 Chlorocebus aethiops Inhibition = 61.0 % PMID[9685238]
NPT3886 Cell line COS-1 Chlorocebus aethiops Inhibition = 70.0 % PMID[9685238]
NPT3886 Cell line COS-1 Chlorocebus aethiops Inhibition = 78.7 % PMID[9685238]
NPT3886 Cell line COS-1 Chlorocebus aethiops Inhibition = 90.3 % PMID[9685238]
NPT3886 Cell line COS-1 Chlorocebus aethiops IC50 = 11090.0 nM PMID[9685238]
NPT1083 Cell line A-375 Homo sapiens IC50 = 16600.0 nM PMID[19615898]
NPT1083 Cell line A-375 Homo sapiens Inhibition = 23.0 % PMID[19615898]
NPT1083 Cell line A-375 Homo sapiens Inhibition = 31.0 % PMID[19615898]
NPT83 Cell line MCF7 Homo sapiens IC50 = 42400.0 nM PMID[19615898]
NPT65 Cell line HepG2 Homo sapiens IC50 = 44500.0 nM PMID[19615898]
NPT139 Cell line HT-29 Homo sapiens IC50 = 61500.0 nM PMID[19615898]
NPT1083 Cell line A-375 Homo sapiens Inhibition = 70.0 % PMID[19615898]
NPT1083 Cell line A-375 Homo sapiens IC50 = 2500.0 nM PMID[19615898]
NPT858 Cell line LNCaP Homo sapiens IC50 <= 10000.0 nM PMID[21123067]
NPT139 Cell line HT-29 Homo sapiens IC50 <= 10000.0 nM PMID[21123067]
NPT83 Cell line MCF7 Homo sapiens IC50 <= 10000.0 nM PMID[21123067]
NPT378 Cell line NCI/ADR-RES Homo sapiens IC50 <= 10000.0 nM PMID[21123067]
NPT111 Cell line K562 Homo sapiens Activity = 170.7 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 168.0 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 331.5 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 615.3 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 477.8 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 597.2 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens IC50 = 5.87 ug.mL-1 PMID[23434529]
NPT111 Cell line K562 Homo sapiens Inhibition = 79.64 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Inhibition = 52.93 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Inhibition = 33.16 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Inhibition = 5.06 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Inhibition = -5.88 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Inhibition = -12.79 % PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 8.527 10'-5/min PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 1.971 10'-4/min PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 2.799 10'-4/min PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 3.976 10'-4/min PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 4.434 10'-4/min PMID[23434529]
NPT111 Cell line K562 Homo sapiens Activity = 4.724 10'-4/min PMID[23434529]
NPT1125 Cell line T98G Homo sapiens GI50 > 50000.0 nM PMID[24080463]
NPT165 Cell line HeLa Homo sapiens GI50 > 50000.0 nM PMID[24080463]
NPT396 Cell line T47D Homo sapiens GI50 = 5360.0 nM PMID[24080463]
NPT401 Cell line 786-0 Homo sapiens GI50 = 4540.0 nM PMID[24080463]
NPT1081 Cell line BXPC-3 Homo sapiens GI50 = 17100.0 nM PMID[24080463]
NPT65 Cell line HepG2 Homo sapiens IC50 = 44500.0 nM PMID[38092421]
NPT83 Cell line MCF7 Homo sapiens IC50 = 42400.0 nM PMID[38092421]
NPT1083 Cell line A-375 Homo sapiens IC50 = 16600.0 nM PMID[38092421]
NPT139 Cell line HT-29 Homo sapiens IC50 = 61500.0 nM PMID[38092421]
NPT941 Cell line HaCaT Homo sapiens IC50 = 85000.0 nM PMID[38092421]
NPT1452 Cell line C8166 Homo sapiens CC50 = 28800.0 nM PMID[19413342]
NPT71 Cell line HEK293 Homo sapiens CC50 > 20000.0 nM DOI[10.6019/CHEMBL4513161]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = -5.2 % DOI[10.21203/rs.3.rs-23951/v1]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.64 % DOI[10.6019/CHEMBL4495565]
NPT20555 Organism SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.0 % DOI[10.6019/CHEMBL4495565]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 5000.0 nM PMID[19615898]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 66.0 % PMID[19615898]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 94.0 % PMID[19615898]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 <= 10000.0 nM PMID[21123067]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 > 50000.0 nM PMID[24080463]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis -logMIC = 4.35 n.a. PMID[28844400]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis -logMIC = 4.95 n.a. PMID[28844400]
NPT20 Organism Candida albicans Candida albicans MIC > 20000.0 nM DOI[10.6019/CHEMBL4513161]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC > 20000.0 nM DOI[10.6019/CHEMBL4513161]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 14800.0 nM PMID[19413342]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe IC50 = 330.0 ug.mL-1 PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Inhibition = 67.72 % PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Inhibition = 44.7 % PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Inhibition = 27.31 % PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Inhibition = 11.51 % PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Inhibition = 4.06 % PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Inhibition = 8.13 % PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Inhibition = 9.48 % PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Activity = 0.00143 /min PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Activity = 0.00245 /min PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Activity = 0.00322 /min PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Activity = 0.00392 /min PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Activity = 0.00425 /min PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Activity = 0.00407 /min PMID[23434529]
NPT765 Organism Schizosaccharomyces pombe Schizosaccharomyces pombe Activity = 0.00401 /min PMID[23434529]
NPT19 Organism Escherichia coli Escherichia coli MIC > 20000.0 nM DOI[10.6019/CHEMBL4513161]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 20000.0 nM DOI[10.6019/CHEMBL4513161]
NPT20950 Cell line Erythrocyte n.a. HC10 > 20.0 uM DOI[10.6019/CHEMBL4513161]
NPT747 Organism Acinetobacter baumannii Acinetobacter baumannii MIC > 20000.0 nM DOI[10.6019/CHEMBL4513161]
NPT2 Others Unspecified n.a. Ratio CC50/EC50 = 2.0 n.a. PMID[19413342]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus Change = -2.66 % PMID[9685239]
NPT32 Organism Mus musculus Mus musculus Change = -2.8 % PMID[9685239]
NPT32 Organism Mus musculus Mus musculus ED50 = 1000.0 mg.kg-1 PMID[19615898]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference
Mus musculus n.a. Cmax = 2970.88 nM PMID[38092421]
Mus musculus Plasma F = 88.29 % PMID[38092421]
Mus musculus Plasma AUC = 2984.54 ng.hr.mL-1 PMID[38092421]
Mus musculus n.a. Cmax = 1231.59 nM PMID[38092421]





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC165106 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.871 High Similarity NPC477886
0.7941 Intermediate Similarity NPC344161
0.7105 Intermediate Similarity NPC227217
0.7105 Intermediate Similarity NPC117780
0.6765 Remote Similarity NPC80241
0.6765 Remote Similarity NPC301641
0.6765 Remote Similarity NPC485483
0.6571 Remote Similarity NPC81067
0.6571 Remote Similarity NPC602945
0.625 Remote Similarity NPC292792
0.5882 Remote Similarity NPC254625
0.5882 Remote Similarity NPC120075
0.5556 Remote Similarity NPC274356
0.5556 Remote Similarity NPC475961
0.5556 Remote Similarity NPC137685
0.5556 Remote Similarity NPC101748
0.5532 Remote Similarity NPC474017
0.5476 Remote Similarity NPC223807
0.5405 Remote Similarity NPC303522
0.5405 Remote Similarity NPC298486
0.5349 Remote Similarity NPC249788
0.5263 Remote Similarity NPC165133
0.5263 Remote Similarity NPC242885
0.5263 Remote Similarity NPC95614
0.5263 Remote Similarity NPC76451
0.5263 Remote Similarity NPC232316
0.5263 Remote Similarity NPC609746
0.5227 Remote Similarity NPC482890
0.5227 Remote Similarity NPC607444
0.5152 Remote Similarity NPC258425
0.5143 Remote Similarity NPC474691
0.5128 Remote Similarity NPC251855
0.5128 Remote Similarity NPC205502
0.5111 Remote Similarity NPC485480

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC165106 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD5283 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data